China Health Technology Group Holding Company Limited (CN Health Tech) reported a sizeable expansion of its equity base for the month ended 30 June 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing on 3 July 2026.
The listed healthcare group completed a rights issue on 17 June 2026—endorsed at its 12 May 2026 general meeting—placing 58.92 million new ordinary shares at HK$0.25 each. This lifted the company’s outstanding share count to 161.84 million from 102.92 million, marking a 57.3% month-on-month increase. Based on the stated issue price, the transaction implies gross proceeds of approximately HK$14.73 million.
Despite the sharp rise in equity, CN Health Tech confirmed its public-float ratio remains above the Main Board’s 25% minimum threshold. No treasury shares were held or cancelled during the period.
Authorised share capital was unchanged at 1.00 billion ordinary shares with a par value of HK$0.10, equivalent to HK$100.00 million. Following the rights issue, the company’s issued share capital (at par) increased to HK$16.18 million from HK$10.29 million.
The filing shows no activity in share option schemes, warrants, convertibles or other share-linked instruments during June 2026.
Comments